Cargando…
Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial
BACKGROUND: There is no sufficient evidence on the effectiveness of acupuncture for neuropathic pain. This protocol describes a study that aims to evaluate the effectiveness and safety of electroacupuncture combined with conventional medicine for patients with intractable neuropathic pain, when comp...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748203/ https://www.ncbi.nlm.nih.gov/pubmed/33371123 http://dx.doi.org/10.1097/MD.0000000000023725 |
_version_ | 1783625073060478976 |
---|---|
author | Moon, Jee Youn Lee, Chang-Soon Yoo, Yongjae Lee, Suji Lee, Sang Hoon Lee, Seunghoon |
author_facet | Moon, Jee Youn Lee, Chang-Soon Yoo, Yongjae Lee, Suji Lee, Sang Hoon Lee, Seunghoon |
author_sort | Moon, Jee Youn |
collection | PubMed |
description | BACKGROUND: There is no sufficient evidence on the effectiveness of acupuncture for neuropathic pain. This protocol describes a study that aims to evaluate the effectiveness and safety of electroacupuncture combined with conventional medicine for patients with intractable neuropathic pain, when compared with conventional medicine alone. METHODS/DESIGN: This study is a prospective, open-labeled, randomized, cross-over clinical trial. A total of 40 patients with neuropathic pain who had a numeric rating scale (NRS) score of over 4 despite receiving conventional treatment for more than 3 months will be enrolled. Participants will receive conventional treatment for neuropathic pain (treatment C) or treatment C combined with 12 additional sessions of electroacupuncture treatment (treatment A) for 6 weeks. Participants will be randomly assigned to 1 of the 2 sequence groups (AC and CA group) with a 1:1 allocation. The differences of responder in the composite efficacy outcomes, which consist of the NRS, Brief Pain Inventory-Short Form (BPI-SF) pain subscale, and global assessment at 6 weeks after randomization will be examined as the primary outcome. Secondary outcomes include differences in the NRS, the Short-Form McGill Pain Questionnaire, BPI-SF, Fatigue Severity Scale, Hospital Anxiety and Depression Scale, Medical Outcomes Study Sleep Scale, global assessment, EQ-5D, and incremental cost-effective ratio at 6 and 15 weeks after randomization. Adverse events, vital signs, and physical examinations will be recorded to evaluate safety. DISCUSSION: The study protocol for this trial will provide up-to-date evidence on the effectiveness and safety of electroacupuncture for patients with intractable neuropathic pain. The results will be disseminated through a peer-reviewed journal and conference presentations. TRIAL REGISTRATION: Clinical Research Information Service, ID: KCT0003615. Registered on March 12, 2019. https://cris.nih.go.kr/cris/search/search_result_st01_kren.jsp?seq=13410& ltype=&rtype= |
format | Online Article Text |
id | pubmed-7748203 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-77482032020-12-21 Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial Moon, Jee Youn Lee, Chang-Soon Yoo, Yongjae Lee, Suji Lee, Sang Hoon Lee, Seunghoon Medicine (Baltimore) 3800 BACKGROUND: There is no sufficient evidence on the effectiveness of acupuncture for neuropathic pain. This protocol describes a study that aims to evaluate the effectiveness and safety of electroacupuncture combined with conventional medicine for patients with intractable neuropathic pain, when compared with conventional medicine alone. METHODS/DESIGN: This study is a prospective, open-labeled, randomized, cross-over clinical trial. A total of 40 patients with neuropathic pain who had a numeric rating scale (NRS) score of over 4 despite receiving conventional treatment for more than 3 months will be enrolled. Participants will receive conventional treatment for neuropathic pain (treatment C) or treatment C combined with 12 additional sessions of electroacupuncture treatment (treatment A) for 6 weeks. Participants will be randomly assigned to 1 of the 2 sequence groups (AC and CA group) with a 1:1 allocation. The differences of responder in the composite efficacy outcomes, which consist of the NRS, Brief Pain Inventory-Short Form (BPI-SF) pain subscale, and global assessment at 6 weeks after randomization will be examined as the primary outcome. Secondary outcomes include differences in the NRS, the Short-Form McGill Pain Questionnaire, BPI-SF, Fatigue Severity Scale, Hospital Anxiety and Depression Scale, Medical Outcomes Study Sleep Scale, global assessment, EQ-5D, and incremental cost-effective ratio at 6 and 15 weeks after randomization. Adverse events, vital signs, and physical examinations will be recorded to evaluate safety. DISCUSSION: The study protocol for this trial will provide up-to-date evidence on the effectiveness and safety of electroacupuncture for patients with intractable neuropathic pain. The results will be disseminated through a peer-reviewed journal and conference presentations. TRIAL REGISTRATION: Clinical Research Information Service, ID: KCT0003615. Registered on March 12, 2019. https://cris.nih.go.kr/cris/search/search_result_st01_kren.jsp?seq=13410& ltype=&rtype= Lippincott Williams & Wilkins 2020-12-18 /pmc/articles/PMC7748203/ /pubmed/33371123 http://dx.doi.org/10.1097/MD.0000000000023725 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 3800 Moon, Jee Youn Lee, Chang-Soon Yoo, Yongjae Lee, Suji Lee, Sang Hoon Lee, Seunghoon Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial |
title | Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial |
title_full | Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial |
title_fullStr | Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial |
title_full_unstemmed | Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial |
title_short | Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial |
title_sort | evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: a prospective, open-labeled, randomized, cross-over clinical trial |
topic | 3800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748203/ https://www.ncbi.nlm.nih.gov/pubmed/33371123 http://dx.doi.org/10.1097/MD.0000000000023725 |
work_keys_str_mv | AT moonjeeyoun evaluationofaneffectivenessandsafetyoftheelectroacupunctureinthemanagementofintractableneuropathicpainaprospectiveopenlabeledrandomizedcrossoverclinicaltrial AT leechangsoon evaluationofaneffectivenessandsafetyoftheelectroacupunctureinthemanagementofintractableneuropathicpainaprospectiveopenlabeledrandomizedcrossoverclinicaltrial AT yooyongjae evaluationofaneffectivenessandsafetyoftheelectroacupunctureinthemanagementofintractableneuropathicpainaprospectiveopenlabeledrandomizedcrossoverclinicaltrial AT leesuji evaluationofaneffectivenessandsafetyoftheelectroacupunctureinthemanagementofintractableneuropathicpainaprospectiveopenlabeledrandomizedcrossoverclinicaltrial AT leesanghoon evaluationofaneffectivenessandsafetyoftheelectroacupunctureinthemanagementofintractableneuropathicpainaprospectiveopenlabeledrandomizedcrossoverclinicaltrial AT leeseunghoon evaluationofaneffectivenessandsafetyoftheelectroacupunctureinthemanagementofintractableneuropathicpainaprospectiveopenlabeledrandomizedcrossoverclinicaltrial |